✦ LIBER ✦

Low-dose chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab in follicular lymphoma

✍ Scribed by Cencini, Emanuele; Fabbri, Alberto; Schiattone, Luana; Bartalucci, Giulia; Bocchia, Monica

Book ID: 126795296
Publisher: John Wiley and Sons
Year: 2014
Tongue: English
Weight: 51 KB
Volume: 94
Category: Article
ISSN: 0902-4441
DOI: 10.1111/ejh.12428

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemoimmunotherapy With Low-Dose Fludara

Chemoimmunotherapy With Low-Dose Fludarabine and Cyclophosphamide and High Dose Rituximab in Previously Untreated Patients With Chronic Lymphocytic Leukemia

✍ Foon, K. A.; Boyiadzis, M.; Land, S. R.; Marks, S.; Raptis, A.; Pietragallo, L.; 📂 Article 📅 2009 🏛 American Society of Clinical Oncology 🌐 English ⚖ 106 KB

Rituximab in combination with fludarabin

Rituximab in combination with fludarabine and cyclophosphamide in the treatment of patients with recurrent follicular lymphoma

✍ Stefano Sacchi; Samantha Pozzi; Raffaella Marcheselli; Massimo Federico; Alessan 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 2 views

## Abstract ## BACKGROUND. The current study was conducted to asses the safety profile and clinical activity of rituximab in combination with fludarabine and cyclophosphamide in patients with recurrent follicular lymphoma (FL). ## METHODS. This study was a noncomparative, multicenter, phase II s

Fludarabine, cyclophosphamide and rituxi

Fludarabine, cyclophosphamide and rituximab as first-line treatment in patients with newly diagnosed follicular lymphoma

✍ De la Cruz Vicente, Fátima; Carrillo-Cruz, Estrella; Rodriguez, Maria Sole; Marí 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 324 KB

Long-term results of chemoimmunotherapy

Long-term results of chemoimmunotherapy with low-dose fludarabine, cyclophosphamide and high-dose rituximab as initial treatment for patients with chronic lymphocytic leukemia

✍ Foon, K. A.; Mehta, D.; Lentzsch, S.; Kropf, P.; Marks, S.; Lenzner, D.; Pietrag 📂 Article 📅 2012 🏛 American Society of Hematology 🌐 English ⚖ 120 KB

Chemoimmunotherapy with modified dosing

Chemoimmunotherapy with modified dosing of fludarabine, cyclophosphamide, and rituximab shows significant clinical activity in patients with previously untreated chronic lymphocytic leukemia

✍ Nicole Lamanna; Mark A. Weiss 📂 Article 📅 2009 🏛 Current Science Inc. 🌐 English ⚖ 164 KB

Fludarabine, Cyclophosphamide and Rituxi

Fludarabine, Cyclophosphamide and Rituximab: an effective chemoimmunotherapy combination with high remission rates for chronic lymphocytic leukaemia

✍ A. Hayat; S. McGuckin; E. Conneally; P. V. Brown; S. R. McCann; M. Lawler; F. Qu 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 174 KB